| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/28/2003 | US6511993 Metalloprotease inhibitors |
| 01/28/2003 | US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/28/2003 | US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death |
| 01/28/2003 | US6511978 Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | US6511976 Having antipsychotic, cardiovascular and gastrokinetic activity |
| 01/28/2003 | US6511973 Enzyme inhibitors of blood coaggulation factor X for use as anticoaggulants in the treatment of cardiovascular diseases associated with thromboses |
| 01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
| 01/28/2003 | US6511941 Synergistic mixture |
| 01/28/2003 | CA2148839C Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 01/27/2003 | CA2394619A1 Polyamino acid-catalysed process for the enantioselective epoxidation of.alpha.,.beta.-unsaturated enones and .alpha.,.beta.-unsaturated sulphones |
| 01/24/2003 | CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/23/2003 | WO2003006506A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | WO2003006495A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 01/23/2003 | WO2003006459A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/23/2003 | WO2003006456A1 4-substituted-picolinic acid amide derivates useful as fungicides |
| 01/23/2003 | WO2003006452A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 01/23/2003 | WO2003006451A1 4-phenylpyran-2-one derivatives |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006444A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | WO2003006440A2 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/23/2003 | WO2003006437A1 Imidazole derivatives as adenosine deaminase inhibitors |
| 01/23/2003 | WO2003006436A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 01/23/2003 | WO2003006431A1 A novel synthesis for heteroarylamine compounds |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006022A1 Tetrahydroquinoline derivatives and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/23/2003 | WO2003006012A1 Compounds and methods for the inhibition of trypanosoma cruz i |
| 01/23/2003 | WO2003005999A2 Methods of treating cytokine mediated diseases |
| 01/23/2003 | WO2002055491A3 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 01/23/2003 | WO2002051808A3 Muscarinic antagonists |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | WO2002046171A3 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 01/23/2003 | WO2002041835A3 Estrogen receptor modulators |
| 01/23/2003 | WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 01/23/2003 | WO2001051472A9 New imidazole derivatives |
| 01/23/2003 | US20030018199 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030018186 Monocyclic L-nucleosides, analogs and uses thereof |
| 01/23/2003 | US20030018067 Cardiovascular disorders; anticancer agents |
| 01/23/2003 | US20030018064 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 01/23/2003 | US20030018062 Deacetylase inhibitors |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 01/23/2003 | US20030018052 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | US20030018050 Indole and 2,3-dihydroindole derivatives, their preparation and use |
| 01/23/2003 | US20030018046 Chemokine receptor binding heterocyclic compounds |
| 01/23/2003 | US20030018041 Spiroindene and spiroindane compounds |
| 01/23/2003 | US20030018035 Central nervous system disorders |
| 01/23/2003 | US20030018029 Tyrosine kinase inhbitor; antiproliferative agents |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030018012 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453396A1 Compounds and methods for the inhibition of trypanosoma cruzi |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | CA2453169A1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | CA2453147A1 Methods of treating cytokine mediated diseases |
| 01/23/2003 | CA2452513A1 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/23/2003 | CA2449243A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | CA2446726A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/23/2003 | CA2418173A1 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 01/23/2003 | CA2417156A1 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient |
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277738A1 Condensed heteroaryl derivatives |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1276740A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
| 01/22/2003 | EP1276737A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
| 01/22/2003 | EP1276726A2 Substituted phenyl farnesyltransferase inhibitors |
| 01/22/2003 | EP1276725A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 01/22/2003 | EP1276723A2 Pyrazole compounds having anti proliferative activity |
| 01/22/2003 | EP1276722A1 Naphthamidine urokinase inhibitors |
| 01/22/2003 | EP1030838B1 Method of synthesis of pyrrole amides |
| 01/22/2003 | EP1030835B1 Urea derivatives and their use as integrin inhibitors |
| 01/22/2003 | EP0828728B1 Phenyl dihydrobenzofuranes |
| 01/22/2003 | EP0782575B1 Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action |
| 01/22/2003 | EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 01/22/2003 | CN1392874A Cyclic amidine compounds |
| 01/22/2003 | CN1392140A Organic compound with di-4-dicyan methyl olefine pyranoid ring and its synthetic method and use |
| 01/22/2003 | CN1099418C Tetrahydro-3-furanyl methylamine |
| 01/22/2003 | CN1099413C Certain fused N-pyrrolylaniline: new class of GABA brain receptor ligand |
| 01/21/2003 | US6509477 Small molecule inhibitors of rotamase enzyme activity |
| 01/21/2003 | US6509469 Process for the production of pyridine derivatives |
| 01/21/2003 | US6509362 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 01/21/2003 | US6509357 1-aryl or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/21/2003 | US6509352 Selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509339 Gastrointestinal disorders; cardiovascular disorders |
| 01/21/2003 | US6509328 Glutamate receptor antagonists |
| 01/16/2003 | WO2003004569A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 01/16/2003 | WO2003004490A1 High molecular weight hydroxyphenylbenzotriazole uv-absorbers for thin film applications |
| 01/16/2003 | WO2003004489A1 Compositions and methods for inhibiting prenyltransferases |
| 01/16/2003 | WO2003004485A1 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 01/16/2003 | WO2003004483A1 Substituted $g(g)-lactone compounds serving as nmda antagonists |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004475A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004466A2 Dye-sulfenates for dual phototherapy |
| 01/16/2003 | WO2003004464A2 Heterocyclic amide derivatives and the use thereof as pesticides |